Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials
Objectives To assess the effect of antihypertensive treatment in the 130–140 mm Hg systolic blood pressure range.Design Systematic review and meta-analysis.Information sources PubMed, CDSR and DARE were searched for the systematic reviews, which were manually browsed for clinical trials. PubMed and...
Saved in:
| Main Authors: | Mattias Brunström, Bo Carlberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/9/e026686.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
by: Bruce Leff, et al.
Published: (2019-08-01) -
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study
by: Reinhold Kreutz, et al.
Published: (2024-12-01) -
More intensive versus conservative blood pressure lowering after endovascular therapy in stroke: a meta-analysis of randomised controlled trials
by: Ahmed Naji Mansoor, et al.
Published: (2025-12-01) -
ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial
by: Kexin Li, et al.
Published: (2025-04-01) -
Lowering blood pressure after acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis using individual patient data from randomised controlled trials participating in the Blood Pressure in Acute Stroke Collaboration (BASC)
by: Keith W Muir, et al.
Published: (2019-07-01)